Skip to main content

Table 2 Results of primary analyses of GDM and control groups

From: Subclinical inflammation associated with prolonged TIMP-1 upregulation and arterial stiffness after gestational diabetes mellitus: a hospital-based cohort study

  GDM Controls p value
hsCRP, mg/L 2.50 ± 3.69 2.50 ± 4.19 0.582
MMP-8, ng/mL 27.83 ± 1.48 32.78 ± 1.90 0.082
MMP-9, ng/mL 384.27 ± 13.15 392.15 ± 12.60 0.667
TIMP-1, ng/mL 102.80 ± 29.72 94.58 ± 24.51 0.020
MMP-8/TIMP-1, mol ratio 0.13 ± 0.009 0.17 ± 0.015 0.035
MMP-9/TIMP-1, mol ratio 1.32 ± 0.078 1.43 ± 0.085 0.152
C1, mL/mmHg × 10 15.14 ± 3.51 15.85 ± 3.36 0.092
C2, mL/mmHg × 100 8.44 ± 3.08 8.60 ± 3.20 0.681
PWV, m/s 6.44 ± 0.83 6.17 ± 0.74 0.009
  1. Data are presented as mean ± SD
  2. hsCRP high-sensitivity C reactive protein, C1 large artery compliance index, C2 small artery compliance index, PWV pulse wave velocity, MMP-8 matrix metalloproteinase-8, MMP-9 matrix metalloproteinase-9